サマリー

淋病治療薬の世界市場 2023-2027
淋病治療薬市場は2022-2027年に5億0668万米ドルで成長し、予測期間中のCAGRは5.47%で加速すると予測されます。この調査レポートは、淋病治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題を掲載し、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、淋病の有病率の上昇、淋病に関連するリスクの高い合併症、新しい診断検査の使用の増加によって牽引されています。
Technavio社の淋病治療薬市場は以下のように区分されます：
流通チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
治療法別
- 単剤療法
- 併用療法
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、抗生物質耐性と闘うための政府のイニシアチブの高まりが、今後数年間の淋病治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、淋病予防のためのワクチンの登場や、迅速なパートナー療法の採用増加も、市場の大きな需要につながるでしょう。
この調査レポートは、淋病治療薬市場を調査・分析し、以下の刊行物を出版しています：
- 淋病治療薬市場のサイジング
- 淋病治療薬市場の予測
- 淋病治療薬市場の産業分析
堅牢なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Apotex Inc.、Aurobindo Pharma Ltd.、Bristol Myers Squibb Co、Cipla Ltd.、Debiopharm International SA、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Hikma Pharmaceuticals Plc、Lupin Ltd.、Mayne Pharma Group Ltd.、Pfizer Inc.、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Therapyx Inc.、Entasis Therapeuticsなどです。また、淋病治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/gonorrhea-therapeutics-market-size-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global gonorrhea therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global gonorrhea therapeutics market 2017 - 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.3 Therapy Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacies - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
o 6.4 Retail pharmacies - Market size and forecast 2022-2027
o Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
o 6.5 Online pharmacies - Market size and forecast 2022-2027
o Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Therapy
o 7.1 Market segments
o Exhibit 48: Chart on Therapy - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Therapy - Market share 2022-2027 (%)
o 7.2 Comparison by Therapy
o Exhibit 50: Chart on Comparison by Therapy
o Exhibit 51: Data Table on Comparison by Therapy
o 7.3 Monotherapy - Market size and forecast 2022-2027
o Exhibit 52: Chart on Monotherapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Monotherapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Monotherapy - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Monotherapy - Year-over-year growth 2022-2027 (%)
o 7.4 Combination therapy - Market size and forecast 2022-2027
o Exhibit 56: Chart on Combination therapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Combination therapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Combination therapy - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Combination therapy - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Therapy
o Exhibit 60: Market opportunity by Therapy ($ million)
o Exhibit 61: Data Table on Market opportunity by Therapy ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Apotex Inc.
o Exhibit 111: Apotex Inc. - Overview
o Exhibit 112: Apotex Inc. - Product / Service
o Exhibit 113: Apotex Inc. - Key offerings
o 12.4 Aurobindo Pharma Ltd.
o Exhibit 114: Aurobindo Pharma Ltd. - Overview
o Exhibit 115: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 116: Aurobindo Pharma Ltd. - Key offerings
o 12.5 Bristol Myers Squibb Co.
o Exhibit 117: Bristol Myers Squibb Co. - Overview
o Exhibit 118: Bristol Myers Squibb Co. - Product / Service
o Exhibit 119: Bristol Myers Squibb Co. - Key news
o Exhibit 120: Bristol Myers Squibb Co. - Key offerings
o 12.6 Cipla Ltd.
o Exhibit 121: Cipla Ltd. - Overview
o Exhibit 122: Cipla Ltd. - Business segments
o Exhibit 123: Cipla Ltd. - Key news
o Exhibit 124: Cipla Ltd. - Key offerings
o Exhibit 125: Cipla Ltd. - Segment focus
o 12.7 Debiopharm International SA
o Exhibit 126: Debiopharm International SA - Overview
o Exhibit 127: Debiopharm International SA - Product / Service
o Exhibit 128: Debiopharm International SA - Key news
o Exhibit 129: Debiopharm International SA - Key offerings
o 12.8 Entasis Therapeutics
o Exhibit 130: Entasis Therapeutics - Overview
o Exhibit 131: Entasis Therapeutics - Product / Service
o Exhibit 132: Entasis Therapeutics - Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus
o 12.10 GlaxoSmithKline Plc
o Exhibit 138: GlaxoSmithKline Plc - Overview
o Exhibit 139: GlaxoSmithKline Plc - Business segments
o Exhibit 140: GlaxoSmithKline Plc - Key news
o Exhibit 141: GlaxoSmithKline Plc - Key offerings
o Exhibit 142: GlaxoSmithKline Plc - Segment focus
o 12.11 Hikma Pharmaceuticals Plc
o Exhibit 143: Hikma Pharmaceuticals Plc - Overview
o Exhibit 144: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 145: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 146: Hikma Pharmaceuticals Plc - Segment focus
o 12.12 Lupin Ltd.
o Exhibit 147: Lupin Ltd. - Overview
o Exhibit 148: Lupin Ltd. - Product / Service
o Exhibit 149: Lupin Ltd. - Key news
o Exhibit 150: Lupin Ltd. - Key offerings
o 12.13 Mayne Pharma Group Ltd.
o Exhibit 151: Mayne Pharma Group Ltd. - Overview
o Exhibit 152: Mayne Pharma Group Ltd. - Business segments
o Exhibit 153: Mayne Pharma Group Ltd. - Key news
o Exhibit 154: Mayne Pharma Group Ltd. - Key offerings
o Exhibit 155: Mayne Pharma Group Ltd. - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 156: Pfizer Inc. - Overview
o Exhibit 157: Pfizer Inc. - Product / Service
o Exhibit 158: Pfizer Inc. - Key news
o Exhibit 159: Pfizer Inc. - Key offerings
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 160: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 161: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 162: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 163: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 164: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 165: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 167: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Therapyx Inc.
o Exhibit 168: Therapyx Inc. - Overview
o Exhibit 169: Therapyx Inc. - Product / Service
o Exhibit 170: Therapyx Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global gonorrhea therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Therapy - Market share 2022-2027 (%)
Exhibits49: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Therapy
Exhibits51: Data Table on Comparison by Therapy
Exhibits52: Chart on Monotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Monotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Monotherapy - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Monotherapy - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Combination therapy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Combination therapy - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Combination therapy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Combination therapy - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Therapy ($ million)
Exhibits61: Data Table on Market opportunity by Therapy ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Apotex Inc. - Overview
Exhibits112: Apotex Inc. - Product / Service
Exhibits113: Apotex Inc. - Key offerings
Exhibits114: Aurobindo Pharma Ltd. - Overview
Exhibits115: Aurobindo Pharma Ltd. - Product / Service
Exhibits116: Aurobindo Pharma Ltd. - Key offerings
Exhibits117: Bristol Myers Squibb Co. - Overview
Exhibits118: Bristol Myers Squibb Co. - Product / Service
Exhibits119: Bristol Myers Squibb Co. - Key news
Exhibits120: Bristol Myers Squibb Co. - Key offerings
Exhibits121: Cipla Ltd. - Overview
Exhibits122: Cipla Ltd. - Business segments
Exhibits123: Cipla Ltd. - Key news
Exhibits124: Cipla Ltd. - Key offerings
Exhibits125: Cipla Ltd. - Segment focus
Exhibits126: Debiopharm International SA - Overview
Exhibits127: Debiopharm International SA - Product / Service
Exhibits128: Debiopharm International SA - Key news
Exhibits129: Debiopharm International SA - Key offerings
Exhibits130: Entasis Therapeutics - Overview
Exhibits131: Entasis Therapeutics - Product / Service
Exhibits132: Entasis Therapeutics - Key offerings
Exhibits133: F. Hoffmann La Roche Ltd. - Overview
Exhibits134: F. Hoffmann La Roche Ltd. - Business segments
Exhibits135: F. Hoffmann La Roche Ltd. - Key news
Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits138: GlaxoSmithKline Plc - Overview
Exhibits139: GlaxoSmithKline Plc - Business segments
Exhibits140: GlaxoSmithKline Plc - Key news
Exhibits141: GlaxoSmithKline Plc - Key offerings
Exhibits142: GlaxoSmithKline Plc - Segment focus
Exhibits143: Hikma Pharmaceuticals Plc - Overview
Exhibits144: Hikma Pharmaceuticals Plc - Business segments
Exhibits145: Hikma Pharmaceuticals Plc - Key offerings
Exhibits146: Hikma Pharmaceuticals Plc - Segment focus
Exhibits147: Lupin Ltd. - Overview
Exhibits148: Lupin Ltd. - Product / Service
Exhibits149: Lupin Ltd. - Key news
Exhibits150: Lupin Ltd. - Key offerings
Exhibits151: Mayne Pharma Group Ltd. - Overview
Exhibits152: Mayne Pharma Group Ltd. - Business segments
Exhibits153: Mayne Pharma Group Ltd. - Key news
Exhibits154: Mayne Pharma Group Ltd. - Key offerings
Exhibits155: Mayne Pharma Group Ltd. - Segment focus
Exhibits156: Pfizer Inc. - Overview
Exhibits157: Pfizer Inc. - Product / Service
Exhibits158: Pfizer Inc. - Key news
Exhibits159: Pfizer Inc. - Key offerings
Exhibits160: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits161: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits162: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits163: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits164: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits165: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits166: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits167: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits168: Therapyx Inc. - Overview
Exhibits169: Therapyx Inc. - Product / Service
Exhibits170: Therapyx Inc. - Key offerings
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations